Barry V. L. Potter, MA DPhil DSc FRSB FRSC MAE FMedSci
Affiliations: | Max-Planck-Institute for Experimental Medicine, Göttingen, Germany | ||
1984-1990 | Biological Chemistry | University of Leicester, Leicester, England, United Kingdom | |
1990- | Medicine & Biological Chemistry | University of Bath, Bath, England, United Kingdom | |
1998-2010 | Sterix Ltd. | ||
2015- | Pharmacology | University of Oxford, Oxford, United Kingdom |
Area:
medicinal chemistry, drug discovery, pharmacologyWebsite:
https://pharm.ox.ac.uk/research/potter-group-medicinal-biological-chemistry-drug-discoveryGoogle:
"Barry Potter"Mean distance: (not calculated yet)
Parents
Sign in to add mentorGordon Lowe | grad student | 1977-1981 | Oxford |
Fritz Eckstein | post-doc | 1981-1983 | Max-Planck-Institute for Experimental Medicine in Goettingen |
Children
Sign in to add traineeMegan Shipton | grad student | Oxford | |
Nicola Howarth | post-doc | University of Bath, England | |
Marie Migaud | post-doc | University of Bath, England | |
Stephen Mills | post-doc | Oxford | |
Kana M. Sureshan | post-doc | University of Bath, England | |
Joanna Watt | post-doc | Oxford | |
Lawrence L.W. Woo | post-doc | University of Bath, England | |
Gerd K Wagner | post-doc | 2002-2004 | University of Bath |
Wolfgang Dohle | research scientist | Oxford | |
Andrew M Riley | research scientist | Oxford | |
Xiangdong Su | research scientist | Oxford |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nel M, Joubert AM, Dohle W, et al. (2018) Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines. Drug Design, Development and Therapy. 12: 1881-1904 |
Fliegert R, Watt JM, Schöbel A, et al. (2017) Ligand induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg 1433 and Tyr 1349. The Biochemical Journal |
Thomas MP, Erneux C, Potter BV. (2016) SHIP2: Structure, Function and Inhibition. Chembiochem : a European Journal of Chemical Biology |
Raimondi C, Calleja V, Ferro R, et al. (2016) A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion. Scientific Reports. 6: 26142 |
El-Gamal MI, Semreen MH, Foster PA, et al. (2016) Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors. Bioorganic & Medicinal Chemistry |
Watson PJ, Millard CJ, Riley AM, et al. (2016) Insights into the activation mechanism of class I HDAC complexes by inositol phosphates. Nature Communications. 7: 11262 |
Mills SJ, Silvander C, Cozier GE, et al. (2016) Crystal Structures of Type-II Inositol Polyphosphate 5-Phosphatase INPP5B with Synthetic Inositol Polyphosphate Surrogates Reveal New Mechanistic Insights for the Inositol 5-Phosphatase Family. Biochemistry |
Thomas MP, Mills SJ, Potter BV. (2015) The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry). Angewandte Chemie (International Ed. in English) |
Shen YC, Upadhyayula R, Cevallos S, et al. (2015) Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol. British Journal of Cancer. 113: 1158-67 |
Thomas MP, Potter BV. (2015) Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential. The Journal of Steroid Biochemistry and Molecular Biology |